|
|
||||||||
a Department of Medicine, Divisions of Geriatrics, Westchester Medical Center/New York Medical College, Valhalla
b Department of Medicine, Divisions of Cardiology, Westchester Medical Center/New York Medical College, Valhalla
Wilbert S. Aronow, CMD, Cardiology Division, New York Medical College, 23 Pebble Way, New Rochelle, NY 10804 E-mail: WSAronow{at}aol.com.
Background. We report the prevalence of use of aspirin, beta blockers, angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers, statins, and calcium channel blockers in older persons with coronary artery disease (CAD) in an academic nursing home.
Methods. We investigated the prevalence of use of aspirin, beta blockers, ACE inhibitors or angiotensin II type 1 receptor blockers, lipid-lowering drugs, and calcium channel blockers in older persons with a mean age of 77 ± 9 years, in an academic nursing home with documented CAD and no contraindications to the use of aspirin, beta blockers, ACE inhibitors or angiotensin II type 1 receptor blockers, and lipid-lowering drugs.
Results. CAD was documented in 77 of 255 persons (30%). Of 77 persons with CAD, 48 persons (62%) were treated with aspirin, 45 persons (58%) with ACE inhibitors or angiotensin II type 1 receptor blockers, 44 persons (57%) with beta blockers, 21 persons (27%) with calcium channel blockers, and 16 persons (21%) with statins. Of the 61 persons with CAD not treated with statins, serum low-density lipoprotein (LDL) cholesterol was measured in only 22 persons (36%) and was increased in 14 of the 22 persons (64%).
Conclusions. These data show underutilization of aspirin, beta blockers, ACE inhibitors, lipid-lowering drugs, and measurement of serum LDL cholesterol and overutilization of calcium channel blockers in older persons with CAD in an academic nursing home.
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
|
S. S Tomlinson and K. K Mangione Potential Adverse Effects of Statins on Muscle Physical Therapy, May 1, 2005; 85(5): 459 - 465. [Full Text] [PDF] |
||||
|
S. Sanal and W. S. Aronow Effect of an Educational Program on the Prevalence of Use of Antiplatelet Drugs, Beta Blockers, Angiotensin-Converting Enzyme Inhibitors, Lipid-Lowering Drugs, and Calcium Channel Blockers Prescribed During Hospitalization and at Hospital Discharge in Patients With Coronary Artery Disease J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M1046 - 1048. [Abstract] [Full Text] [PDF] |
||||
|
D. Tsilimingras, A. K. Rosen, and D. R. Berlowitz Review Article: Patient Safety in Geriatrics: A Call for Action J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2003; 58(9): M813 - 819. [Abstract] [Full Text] [PDF] |
||||
|
W. S. Aronow and C. Ahn Elderly Diabetics With Peripheral Arterial Disease and No Coronary Artery Disease Have a Higher Incidence of New Coronary Events Than Elderly Nondiabetics With Peripheral Arterial Disease and Prior Myocardial Infarction Treated With Statins and With No Lipid-Lowering Drug J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2003; 58(6): M573 - 575. [Abstract] [Full Text] [PDF] |
||||
|
S. Ghosh and W. S. Aronow Utilization of Lipid-Lowering Drugs in Elderly Persons With Increased Serum Low-Density Lipoprotein Cholesterol Associated With Coronary Artery Disease, Symptomatic Peripheral Arterial Disease, Prior Stroke, or Diabetes Mellitus Before and After an Educational Program on Dyslipidemia Treatment J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): M432 - 435. [Abstract] [Full Text] [PDF] |
||||
|
J. E. Morley Editorial: Hot Topics in Geriatrics J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2003; 58(1): M30 - 36. [Full Text] [PDF] |
||||
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
---|
All GSA journals | The Gerontologist |
Journals of Gerontology Series B: Psychological Sciences and Social Sciences |